TAO WU to Mutation
This is a "connection" page, showing publications TAO WU has written about Mutation.
Connection Strength
0.130
-
Menin inhibitor MI-3454 induces remission in MLL1-rearranged and NPM1-mutated models of leukemia. J Clin Invest. 2020 02 03; 130(2):981-997.
Score: 0.061
-
Anlotinib combined with benmelstobart as a chemo-free first-line treatment in advanced esophageal squamous cell carcinoma: an exploratory multicenter, single-arm phase II clinical trial. Mol Cancer. 2025 Jun 11; 24(1):175.
Score: 0.022
-
GmUFO1 Regulates Floral Organ Number and Shape in Soybean. Int J Mol Sci. 2023 Jun 02; 24(11).
Score: 0.019
-
VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma. Science. 2018 07 20; 361(6399):290-295.
Score: 0.014
-
Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor. Cell. 2018 01 25; 172(3):578-589.e17.
Score: 0.013